Stockreport

Eyepoint +1.9% as Guggenheim starts at Buy [Seeking Alpha]

EyePoint Pharmaceuticals, Inc.  (EYPT) 
Last eyepoint pharmaceuticals, inc. earnings: 3/5 07:00 am Check Earnings Report
PDF Eyepoint +1.9% as Guggenheim starts at Buy Eyepoint Pharmaceuticals (NASDAQ: EYPT up 1.9% The firm has set its price target to $4, implying 150% upside from today's clos [Read more]